Literature DB >> 2900143

Comparison of the acute haemodynamic effects of bopindolol and propranolol at rest and during supine exercise.

P Fitscha1, W Meisner, B Tiso.   

Abstract

The acute cardiovascular effects of two beta-adrenoceptor blocking agents, bopindolol and propranolol, were compared in a randomized study in 16 male patients with coronary heart disease. All patients had had an uncomplicated acute myocardial infarction at least 8 weeks earlier. The two drugs reduced the arterial blood pressure to the same extent, both at rest and during exercise. As heart rate and stroke volume were also decreased, cardiac output was reduced, whereas systemic vascular resistance was increased at rest and during exercise. Left ventricular filling pressure was increased. No statistically significant differences in these variables were seen between the two groups.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900143     DOI: 10.1007/bf00542436

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  The significance of beta1-beta2-selectivity and intrinsic sympathomimetic activity in beta-blockers, with particular reference to antihypertensive treatment.

Authors:  P Imhof
Journal:  Adv Clin Pharmacol       Date:  1976

2.  Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers.

Authors:  T L Svendsen; O Hartling; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

3.  Haemodynamic effects of beta-adrenergic blockade.

Authors:  H Aström
Journal:  Br Heart J       Date:  1968-01

4.  Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest.

Authors:  T L Svendsen; O J Hartling; J Trap-Jensen; A McNair; J Bliddal
Journal:  Clin Pharmacol Ther       Date:  1981-06       Impact factor: 6.875

5.  Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.

Authors:  W H Aellig; E Nüesch; G Engel; J Grevel; W Niederberger; J Rosenthaler
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

6.  Speed of onset of pharmacodynamic activity of propranolol, practolol, oxprenolol and metoprolol after intravenous infection in man.

Authors:  R Lochan; B Silke; S H Taylor
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

7.  Simultaneous modeling of bopindolol kinetics and dynamics.

Authors:  R Platzer; R L Galeazzi; W Niederberger; J Rosenthaler
Journal:  Clin Pharmacol Ther       Date:  1984-07       Impact factor: 6.875

8.  A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man.

Authors:  T L Svendsen; J E Carlsen; O Hartling; A McNair; J Trap-Jensen
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

9.  Influence of atenolol and bopindolol on circadian heart rate.

Authors:  P Fitscha; W Meisner; B Tiso
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

  9 in total
  2 in total

Review 1.  Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  D W Harron; K L Goa; H D Langtry
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  Comparison of bopindolol and atenolol in chronic stable angina pectoris.

Authors:  P Fitscha; W Meisner; B Tiso
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.